Kim Alving

Title: Kim Alving: Innovator in Pancreatic Cancer Research

Introduction

Kim Alving is a prominent inventor based in Rockville, MD (US). She has made significant contributions to the field of medical research, particularly in the diagnosis and treatment of pancreatic diseases. Her innovative work has the potential to impact the lives of many patients suffering from pancreatic cancer.

Latest Patents

Kim Alving holds a patent titled "Pancreatic cancer secreted targets and uses thereof." This invention provides a method for diagnosing and detecting diseases associated with the pancreas. It introduces one or more proteins or fragments thereof, peptides, or nucleic acid molecules that are differentially expressed in pancreatic diseases (PCAST). Additionally, the patent describes antibodies that bind to PCAST and outlines methods for treating diseases associated with the pancreas. This groundbreaking work is crucial for advancing the understanding and management of pancreatic cancer.

Career Highlights

Throughout her career, Kim has been associated with Applera Corporation, where she has been able to apply her expertise in innovative research. Her dedication to improving diagnostic methods and treatment options for pancreatic diseases has established her as a key figure in her field.

Collaborations

Kim Alving has collaborated with notable professionals in her field, including Ian McCaffey and Bruno Domon. These partnerships have further enhanced her research and contributed to the development of her patented technologies.

Conclusion

Kim Alving's work in pancreatic cancer research exemplifies the impact of innovation in medicine. Her patent and collaborations highlight her commitment to advancing healthcare solutions for pancreatic diseases.